Metyrapone for depression and delirium secondary to Cushing's syndrome

Psychosomatics

Volumn 26, Issue 1, 1985, Pages 67-

  Kramlinger, Keith G ^a   Peterson, Gerald C ^a   Watson, Patricia K ^a   Leonard, Lazaro L ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; METYRAPONE;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CUSHING DISEASE; DELIRIUM; DEPRESSION; DIAGNOSIS; DRUG EFFICACY; ENDOCRINE SYSTEM; HUMAN; PERIPHERAL NERVOUS SYSTEM; PSYCHOLOGICAL ASPECT; PSYCHOSIS;

EID: 0021927242     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(85)72906-4     Document Type: Letter

References (8)

1. Neuropsychiatric aspects of Cushing's syndrome
2. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances
3. Neuropsychiatric manifestations of patients with Cushing's syndrome: Relationship to cortisol and adrenocorticotrophic hormone levels
4. Presentation of the steroid psychoses
5. Metyrapone is useful only as adjunctive therapy in Cushing's disease
6. The Cushing's syndromes: Changing views of diagnosis and treatment
7. Psychiatric manifestations of Cushing's syndrome. Response to lowering of plasma cortisol